Harrow Reaffirms Its 2025 Full-Year Revenue Guidance, Launches OneHarrow Initiative

Published on February 3, 2026
LAKE FOREST, Calif.—Harrow (Nasdaq: HROW), a North American provider of ophthalmic disease management solutions, has reaffirmed its full-year 2025 revenue guidance, projecting revenue between $270 million and $280 million. The company also advised that it is moving forward with several strategic initiatives, including plans to double its Vevye (eye drop for dry eyes) sales force by May 25, 2026, expand the use of Iheezo (topical ocular anesthetic) in office settings, and double its surgical-based sales force dedicated to Triesence (a preservative free synthetic corticosteroid for visualization during vitrectomy and for the treatment of ocular inflammatory conditions).
Continue reading on website
Other news

American College of Eye Technicians Appoints Hayley G. Boling to Advisory Board

February 3, 2026
MIAMI—The American College of Eye Technicians (ACET), a nonprofit dedicated to the recruitment and development of aspiring eye assistants, has appointed Hayley G. Boling to its volunteer advisory board. Boling is a third-generation medical entrepreneur and chief executive officer of Boling Vision Center and affiliated eyecare businesses, leading a multisite team that includes a joint commission, a

Vision Innovation Partners Acquires Ophthalmic Associates of Alexandria

February 3, 2026
ANNAPOLIS, Md.—Vision Innovation Partners (VIP), a leading Mid-Atlantic eyecare platform with nearly 70 locations, announced that it has acquired Ophthalmic Associates of Alexandria, a comprehensive ophthalmology practice located in downtown Alexandria, Va. This acquisition marks VIP’s 27th add-on since its founding in 2017 and complements its growing network of ophthalmology practices, the compan